Gainers
- Akebia Therapeutics (NASDAQ:AKBA) stock moved upwards by 25.7% to $0.93 during Thursday's after-market session. This security traded at a volume of 1.6 million shares come close, making up 75.7% of its average volume over the last 100 days. The company's market cap stands at $171.0 million.
- Lipocine (NASDAQ:LPCN) stock increased by 17.29% to $0.53. The market value of their outstanding shares is at $46.8 million.
- Anixa Biosciences (NASDAQ:ANIX) shares rose 16.58% to $4.5. The company's market cap stands at $139.1 million.
- ABVC BioPharma (NASDAQ:ABVC) shares rose 9.56% to $0.8. Trading volume for this security closed at 296.4K, accounting for 36.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $26.1 million.
- Insulet (NASDAQ:PODD) stock moved upwards by 7.19% to $319.0. The company's market cap stands at $22.1 billion. The company's, Q4 earnings came out today.
- Medigus (NASDAQ:MDGS) shares moved upwards by 7.14% to $4.95. The market value of their outstanding shares is at $8.1 million.
Losers
- SELLAS Life Sciences Gr (NASDAQ:SLS) shares decreased by 33.6% to $2.45 during Thursday's after-market session. At the close, SELLAS Life Sciences Gr's trading volume reached 126.2K shares. This is 75.9% of its average volume over the last 100 days. The company's market cap stands at $50.4 million.
- Tactile Systems Tech (NASDAQ:TCMD) stock decreased by 13.76% to $12.35. The company's market cap stands at $250.0 million. As per the press release, Q4 earnings came out 2 days ago.
- Benitec Biopharma (NASDAQ:BNTC) stock declined by 6.91% to $0.24. The company's market cap stands at $6.7 million.
- Ontrak (NASDAQ:OTRK) stock decreased by 5.74% to $0.62. The company's market cap stands at $16.9 million.
- Nexalin Technology (NASDAQ:NXL) shares decreased by 5.46% to $0.84. The company's market cap stands at $6.0 million.
- Vir Biotechnology (NASDAQ:VIR) shares declined by 4.97% to $24.5. Trading volume for this security closed at 93.7K, accounting for 11.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.2 billion. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AKBAAkebia Therapeutics Inc
$1.60-1.85%
ANIXAnixa Biosciences Inc
$5.03-1.95%
BNTCBenitec Biopharma Inc
$12.81-%
LPCNLipocine Inc
$3.475.18%
NXLNexalin Technology Inc
$0.98991.21%
OTRKOntrak Inc
$0.0601-81.8%
PODDInsulet Corp
$295.700.17%
SLSSELLAS Life Sciences Group Inc
$1.970.35%
TCMDTactile Systems Technology Inc
$28.66-0.38%
VIRVir Biotechnology Inc
$6.681.98%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
